Alpha Pro Tech Ltd (APT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alpha Pro Tech Ltd   (NYSEAMER: APT)


Alpha Pro Tech Ltd's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alpha Pro Tech Ltd's ROI in the second quarter of 2026?
Alpha Pro Tech Ltd achieved a return on average invested assets (ROI) of 13.8 % in its second quarter of 2026, which is below Alpha Pro Tech Ltd's average return on investment, which stands at 23.07%.

ROI has improved compared to 11.97% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 60 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 623 to 666.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 0.55 % -0.41 % -0.85 % 0.92 % 4.06 %
Y / Y Net Income Change TTM 20.04 % -7.02 % 7.18 % 47.38 % 116 %
Investment (TTM) in Millions 72 70 70 70 70
Return On Investment (TTM) 13.8 % 11.97 % 11.7 % 12.02 % 11.56 %
APT's Overall Ranking # 666 # 623 # 501 # 297 # 502
Seq. Investment Change TTM 0.72 % 0.17 % -0.19 % -0.15 % -0.24 %
Seq. Net Income Change TTM 16.13 % 2.46 % -2.8 % 3.79 % -10.05 %
Net Income (TTM) in Millions 10 8 8 8 8

APT Company Profile >> Back to APT Roi Comparisons >> See Annual APT Return On Investment



Return On Investment APT's Ranking
Within: No.
Industry # 15
Sector # 61
Overall # 666

Return On Investment Statistics
High Average Low
112.39 %
23.07 %
6.35 %
(Dec 31 2020)   (Dec 31 2012)







Financial Statements
Alpha Pro Tech Ltd's II. Quarter Investments $ 72 Millions APT's Balance sheet
Alpha Pro Tech Ltd's II. Quarter Income $ 4 Millions Quarterly APT's Income Statement
APT's Income by Division See APT's Income by Division


APT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 70 71 66 62 65
Y / Y Investment Growth -0.77 % 6.68 % 6.09 % -4.34 % 3.62 %
Net Income in Millions 8 9 10 8 15
Y / Y Net Income Growth -8.37 % -6.92 % 25.23 % -49.68 % -74.29 %
Annual Return On Investment 11.7 % 12.67 % 14.52 % 12.3 % 23.39 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 11.7 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
APT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for APT's Competitors
Subscribers only: Roi for Alpha Pro Tech Ltd's Suppliers
Subscribers only: Return On Investment for APT's Customers

Other Ratios
APT's Roa APT's Inventory Turnover Ratio APT's Growth Rates APT's Dividend Statistics
APT's Profitability Ratios APT's Asset Turnover Ratio APT's Dividend Growth
APT's Roe APT's Valuation Ratios APT's Financial Strength Ratios APT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %

Date modified: 2026-09-08T16:32:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.